MiniMed (Nasdaq:MMED) announced today that it appointed David Endicott and Linnea Burman to its board of directors, effective today. The appointments of Endicott and Burman expand the board from nine members to 11 members. Endicott, currently the CEO of Alcon, also joins the board’s Compensation and Talent Committee with the appointment. Northridge, California-based MiniMed’s latest […]
MiniMed
MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe
MiniMed (Nasdaq:MMED) announced today that it launched two insulin delivery platforms with the Instinct sensor made by Abbott in Europe. The Northridge, California-based former Medtronic Diabetes unit launched its MiniMed 780G automated insulin delivery system integrated with Instinct, along with the MiniMed Go system paired with the Instinct Go sensor. Both sensors, made by Abbott […]
MiniMed begins miniature Flex pump rollout in US
MiniMed (Nasdaq:MMED) announced today that it kicked off its first commercial launch of its Flex automated insulin delivery system in the U.S. The launch comes a few months after the system picked up FDA clearance in March. Northridge, California-based MiniMed, the former Medtronic Diabetes unit, designed Flex, its smallest insulin pump yet, as its first […]
The biggest diabetes tech news out of ADA 2026
The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation automated insulin delivery platforms, continuous glucose monitors (CGMs) and all kinds of other technologies were on display in New Orleans. BTIG analysts Marie Thibault, Alexandra Pang and Sam Eiber […]
MiniMed adds Abbott dual glucose-ketone sensor to portfolio, posts Q4 sales beat
MiniMed (Nasdaq:MMED) announced today that it expanded its agreement with Abbott (NYSE:ABT) to add more sensors to its portfolio. The company also announced fourth-quarter earnings results in tandem with the new Abbott integration. MiniMed has an existing partnership with Abbott through a collaboration between the companies agreed in 2024. They integrated Instinct, a sensor made by […]
MiniMed launches MiniMed Go smart multiple daily injection system in US
MiniMed (Nasdaq:MMED) announced today that it began the U.S. launch of MiniMed Go, a connected smart multiple daily injection (MDI) system. The smart MDI system integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within a mobile app to deliver real-time, personalized insights and actionable guidance. The platform targets people […]
New data backs MiniMed 780G pump, SmartGuard algorithm across CGM types
MiniMed (Nasdaq:MMED) today shared findings from a new randomized crossover study backing the use of its 780 automated insulin pump. Findings demonstrated virtually identical glycemic outcomes for users of the pump across two different continuous glucose monitors (CGMs). Investigators published data today in Diabetes Technology & Therapeutics. MiniMed says outcomes reinforce that its automated insulin […]
MassDevice’s Continuous Glucose Monitoring (CGM) Market Special Report
The multi-billion dollar CGM market is expected to experience substantial, double-digit percentage growth over the next five years. MassDevice’s free CGM Market Special Report provides a detailed market forecast, including CGM sales growth forecasts for the individual companies in the space including Abbott, Dexcom, Medtronic and Senseonics. This extensive report includes epidemiology data, clinical overview, medical device […]
Analysts initiate MiniMed with ‘Buy’ rating in competitive diabetes tech space
BTIG analysts today opened coverage for MiniMed (Nasdaq:MMED) with optimism about the company’s scale, reach and potential pipeline. Marie Thibault, Alexandra Pang and Sam Eiber initiated MiniMed with a “Buy” rating following the Medtronic Diabetes business’ recent initial public offering (IPO), despite the IPO coming up short of its initial target price. “Our MiniMed Group […]
Medtronic cuts 2026 guidance on private equity charge related to MiniMed approval
Medtronic (NYSE:MDT) said in an SEC filing that it lowered its full-year guidance after a one-time charge related to its MiniMed diabetes unit. Despite the guidance news filed yesterday, MDT shares are up slightly over the past five days. The S&P 500 is also up a bit. Last week, MiniMed announced FDA clearance for the […]
MiniMed wins FDA clearance for next-gen Flex insulin pump
MiniMed (Nasdaq:MMED) achieved its first major FDA clearance since its initial public offering (IPO), adding a new pump to its offerings. Our sister site, Drug Delivery Business News, reports today that the company announced that it received FDA clearance for the MiniMed Flex next-generation insulin pump. Flex, a discreet, smartphone-controlled insulin pump, was designed by […]
